[1]
Saad, F. et al. 2018. Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidence. Canadian Urological Association Journal. 12, 9 (May 2018), E415–20. DOI:https://doi.org/10.5489/cuaj.5154.